These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11550822)

  • 21. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative evaluation of the instant-view 5-panel test card with OnTrak TesTcup Pro 5: comparison with gas chromatography-mass spectrometry.
    Moody DE; Fang WB; Andrenyak DM; Monti KM; Jones C
    J Anal Toxicol; 2006; 30(1):50-6. PubMed ID: 16620532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of adulterating agents on FPIA analysis of urine for drugs of abuse.
    Schwarzhoff R; Cody JT
    J Anal Toxicol; 1993; 17(1):14-7. PubMed ID: 8429620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and interpretation of lysergic acid diethylamide results by immunoassay screening of urine in various testing groups.
    Wu AH; Feng YJ; Pajor A; Gornet TG; Wong SS; Forte E; Brown J
    J Anal Toxicol; 1997; 21(3):181-4. PubMed ID: 9171199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determining the effects of adulterants on drug detection via enzyme-linked immunosorbent assay and adulterant tests strips.
    Olivieri B; Marić M; Bridge C
    Drug Test Anal; 2018 Sep; 10(9):1383-1393. PubMed ID: 29749024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine drug-testing tampering approaches: Turkish probationers.
    Aydoğdu M; Akgür SA
    Med Sci Law; 2021 Jan; 61(1):6-13. PubMed ID: 32924786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A field evaluation of five on-site drug-testing devices.
    Crouch DJ; Hersch RK; Cook RF; Frank JF; Walsh JM
    J Anal Toxicol; 2002 Oct; 26(7):493-9. PubMed ID: 12423006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Method comparison of the Ortho Vitros Fusion 5,1 chemistry analyzer and the Roche COBAS Integra 400 for urine drug screen testing in the emergency department.
    Johnson-Davis KL; Thompson CD; Clark CJ; McMillin GA; Lehman CM
    J Anal Toxicol; 2012 Jun; 36(5):345-8. PubMed ID: 22582270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in whole blood of drivers involved in road accidents.
    Pelletti G; Garagnani M; Rossi F; Roffi R; Barone R; Pelotti S
    Forensic Sci Int; 2019 Jan; 294():27-33. PubMed ID: 30447484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urine adulterant test for oxidants yields positive results from microbial-contaminated urine.
    Brazwell E; Crossey M; Racz M; Quitoriano T; Chavez M
    J Anal Toxicol; 2004; 28(8):692-3. PubMed ID: 15586447
    [No Abstract]   [Full Text] [Related]  

  • 32. Papain adulteration in 11-nor-Delta9-tetrahydrocannabinol- 9-carboxylic acid-positive urine samples.
    Larson SJ; Holler JM; Magluilo J; Dunkley CS; Jacobs A
    J Anal Toxicol; 2008; 32(6):438-43. PubMed ID: 18652751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multiple-site laboratory evaluation of three on-site urinalysis drug-testing devices.
    Crouch DJ; Frank JF; Farrell LJ; Karsch HM; Klaunig JE
    J Anal Toxicol; 1998 Oct; 22(6):493-502. PubMed ID: 9788525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on Urine Adulterants and Synthetic Urine Samples to Subvert Urine Drug Testing.
    Vikingsson S; Krauss ST; Winecker RE; Flegel RR; Hayes ED
    J Anal Toxicol; 2022 Aug; 46(7):697-704. PubMed ID: 35639619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a nonisotopic immunoassay for the detection of LSD in human urine.
    Cassells NP; Craston DH; Hand CW; Baldwin D
    J Anal Toxicol; 1996 Oct; 20(6):409-15. PubMed ID: 8889677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse.
    Beck O; Rausberg L; Al-Saffar Y; Villen T; Karlsson L; Hansson T; Helander A
    Drug Test Anal; 2014 May; 6(5):492-9. PubMed ID: 24665024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectrophotometric detection of iodide and chromic (III) in urine after oxidation to iodine and chromate (VI).
    Paul BD; Jacobs A
    J Anal Toxicol; 2005 Oct; 29(7):658-63. PubMed ID: 16419396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration.
    Smith ML; Shimomura ET; Summers J; Paul BD; Nichols D; Shippee R; Jenkins AJ; Darwin WD; Cone EJ
    J Anal Toxicol; 2000 Oct; 24(7):522-9. PubMed ID: 11043654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine.
    Dasgupta A
    Am J Clin Pathol; 2007 Sep; 128(3):491-503. PubMed ID: 17709324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated urine zinc concentration reduces the detection of methamphetamine, cocaine, THC and opiates in urine by EMIT.
    Lin CN; Strathmann FG
    J Anal Toxicol; 2013; 37(9):665-9. PubMed ID: 23843421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.